Elicio Therapeutics, Inc. is a clinical-stage biotechnology company, which engages in the development of cancer immunotherapies. It focuses on its Amphiphile platform for trafficking lymph nodes. The company was founded by Darrell Irvine in August 2011 and is headquartered in Boston, MA.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
32
Frequently Asked Questions
What is Market Cap of Elicio Therapeutics Inc.?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Elicio Therapeutics Inc. market cap is $164.69M.
What is the 52-week high for Elicio Therapeutics Inc.?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Elicio Therapeutics Inc. 52 week high is $12.42 as of September 17, 2025.
What is the 52-week low for Elicio Therapeutics Inc.?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Elicio Therapeutics Inc. 52 week low is $4.05 as of September 17, 2025.
What is Elicio Therapeutics Inc. stock price today?
Elicio Therapeutics Inc. stock price today is $11.35.
What was Elicio Therapeutics Inc. stock price yesterday?
Elicio Therapeutics Inc. stock price yesterday was $10.08.
What is the PE ratio of Elicio Therapeutics Inc.?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Elicio Therapeutics Inc.’s P/E ratio is -2.41.
What is the Price-to-Book ratio of Elicio Therapeutics Inc.?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Elicio Therapeutics Inc. P/B ratio is 89.3855.
What is the 50-day moving average of Elicio Therapeutics Inc.?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Elicio Therapeutics Inc. 50-day moving average is $10.03.
How many employess does Elicio Therapeutics Inc. has?
